Vireo Growth (VREOF) Inventory Average (2021 - 2026)
Vireo Growth (VREOF) reported Inventory Average of $68.0 million for Q1 2026, up 202.38% on a YoY basis from $22.5 million in Q1 2025, and up 19.49% sequentially from $57.0 million in Q4 2025.
Vireo Growth (VREOF) Inventory Average (2021 - 2026) Analysis & Trends
Vireo Growth (VREOF) has 6 years of Inventory Average data on file, last reported at $68.0 million in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average rose 202.38% year-over-year to $68.0 million; the trailing twelve-month figure through Mar 2026 stood at $68.0 million (up 202.38% YoY), and the FY2025 full-year result was $40.8 million, up 99.42% from the prior year.
- Inventory Average rose to $68.0 million in Q1 2026, from $57.0 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $68.0 million in Q1 2026 to a low of $18.4 million in Q2 2022.
- A 5-year average of $28.6 million and a median of $20.0 million in 2024 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average decreased 8.77% in 2024 and surged 202.38% in 2026, its largest moves.
- Tracing VREOF's Inventory Average over 5 years: stood at $19.8 million in 2022, then retreated by 3.23% to $19.2 million in 2023, then advanced by 8.27% to $20.8 million in 2024, then surged by 174.38% to $57.0 million in 2025, then grew by 19.49% to $68.0 million in 2026.
- Business Quant data shows VREOF's Inventory Average at $68.0 million in Q1 2026, $57.0 million in Q4 2025, and $58.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 1.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.18 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 2.51 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 9.02 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 180.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.11 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 3.96 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 66.75 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 1.73 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 68.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.05 Mn |
| Dec 31, 2025 | 56.95 Mn |
| Sep 30, 2025 | 58.47 Mn |
| Jun 30, 2025 | 43.19 Mn |
| Mar 31, 2025 | 22.50 Mn |
| Dec 31, 2024 | 20.76 Mn |
| Sep 30, 2024 | 19.97 Mn |
| Jun 30, 2024 | 19.72 Mn |
| Mar 31, 2024 | 19.32 Mn |
| Dec 31, 2023 | 19.17 Mn |
| Sep 30, 2023 | 19.42 Mn |
| Jun 30, 2023 | 20.82 Mn |
| Mar 31, 2023 | 21.18 Mn |
| Dec 31, 2022 | 19.81 Mn |
| Sep 30, 2022 | 18.86 Mn |
| Jun 30, 2022 | 18.43 Mn |
| Mar 31, 2022 | 19.34 Mn |
| Dec 31, 2021 | 20.28 Mn |
| Sep 30, 2021 | 18.43 Mn |
| Jun 30, 2021 | 15.63 Mn |